Understanding early Rett Syndrome development
Official title: Early developmental mechanisms of Rett Syndrome
Funded at Massachusetts Institute of Technology · NIH-11009544 · Data updated 2026-11-12
This research explores how Rett Syndrome begins in very early development to find new ways to help girls affected by this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | December 1, 2009 |
| Project end | January 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $387,750 |
| NIH project number | 5R01MH085802-15 |
| Project ID | NIH-11009544 on NIH RePORTER |
Who could benefit from this research
✓Could help
This foundational research is relevant to girls and women living with Rett Syndrome and their families, as it seeks to understand the very origins of the condition.
✕Less likely to help
Patients not affected by Rett Syndrome would not directly benefit from this specific research.
What this research studies
Rett Syndrome is a serious condition that mainly affects girls, caused by changes in a gene called MECP2. While we know this gene is important throughout life, recent findings suggest that the earliest signs of Rett Syndrome appear much sooner than previously thought. This project uses advanced stem cell technology, including patient-derived cells, to create tiny brain models called organoids. By observing these models with special microscopes and molecular tools, we aim to understand exactly how the MECP2 gene changes affect brain cell development and movement in the earliest stages of life.
Why it matters
Potential benefit: If successful, this work could uncover critical early events in Rett Syndrome, leading to new strategies for early diagnosis and potential treatments.
How similar studies have gone: The researchers have previously shown that reduced MECP2 in patient-derived cells leads to specific issues in brain cell development, building on existing knowledge.
Where this research is happening
-
Massachusetts Institute of Technology
Cambridge, United States Active
Researchers
- Principal investigator: Sur, Mriganka — Massachusetts Institute of Technology
- Study coordinator: Sur, Mriganka
Related research
Other NIH-funded projects on the same topics.
-
Neuronal Cholesterol Enzyme CYP46A1 and Rett Syndrome biology
A study in Rett syndrome explores whether tweaking a brain cholesterol enzyme called CYP46A1 could help with the disease by affecting brain pathways involved in Rett.
-
Neurophysiological biomarkers to speed Rett syndrome therapies
A study to find measurable brain signals that show whether treatments are helping children with Rett syndrome.
-
MeCP2 reactivation on the inactive X to treat Rett syndrome
This project explores turning on the silent MECP2 gene on the inactive X chromosome to help people with Rett syndrome feel better.
-
Glial signaling and breathing in Rett syndrome
Aims to understand how brain support cells (glia) in Rett syndrome affect breathing and whether IGF-1 related signals can improve it.
-
Studying how deep brain stimulation helps Rett syndrome in mice
Researchers are testing how deep brain stimulation affects brain cells and memory in a mouse model of Rett syndrome to uncover mechanisms that could guide future therapies.
-
Molecular Pathways Behind Rett Syndrome in Humans
A patient-focused look at how changes in the MECP2 gene affect brain function and development in Rett syndrome.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.